Sinonasal malignancy: ESMO–EURACAN Clinical Practice Guideline for diagnosis, treatment and follow-up
Published online: 6 February 2025 - ESMO Open
Resteghini C, Baujat B, Bossi P, et al., on behalf of the ESMO Guidelines Committee
- The CPG provides key recommendations and algorithms for managing SMs, excluding mucosal melanoma and soft tissue sarcomas.
- The guideline covers diagnosis, staging, risk assessment, treatment and disease monitoring.
- Technological advancements in treatment with RT are discussed with a special focus on particle therapy.
- Surgical indications for open and transnasal endoscopic surgery are provided.
- Neoadjuvant chemotherapy in high-grade, locally advanced SMs helps to select subjects for conservative treatments.